Real-World Outcomes of Patients with Advanced Lung Adenocarcinoma Treated with First-Line Chemo-Immunotherapy in Italy

被引：0

作者：

Perrone, A. Leonetti F. ^{[1
]}

Puntoni, M. ^{[2
]}

Bordi, P. ^{[1
]}

Maglietta, G. ^{[2
]}

Carpana, C. ^{[3
]}

Gelsomino, F. ^{[4
]}

Passiglia, F. ^{[5
]}

Genova, C. ^{[6
]}

Montrone, M. ^{[7
]}

Caliman, E. ^{[8
]}

Cerea, G. ^{[9
]}

Pasello, G. ^{[10
]}

Cecere, F. ^{[11
]}

Manzo, A. ^{[12
]}

Adamo, V. ^{[13
]}

Citarella, F. ^{[14
]}

Toschi, L. ^{[15
]}

Gelibter, A. ^{[16
]}

Rastelli, F. ^{[17
]}

Carta, A. ^{[18
]}

Guida, A. ^{[19
]}

Camerini, A. ^{[20
]}

Paoloni, F. ^{[21
]}

Bertolini, F. ^{[22
]}

Tiseo, M. ^{[3
]}

机构：

[1] Univ Hosp Parma, Med Oncol Unit, Parma, Italy

[2] Univ Hosp Parma, Clin Epidemiol Res Unit, Parma, Italy

[3] Univ Parma, Dept Med & Surg, Parma, Italy

[4] Univ Bologna, Med Oncol, IRCCS Azienda Osped, Bologna, Italy

[5] Univ Turin, Dept Oncol, AOU San Luigi Gonzaga, Turin, Italy

[6] IRCCS Osped Policlinico San Martino, Acad Oncol Unit, Genoa, Italy

[7] IRCCS Ist Tumori Giovanni Paolo II, Med Thorac Oncol Unit, Bari, Italy

[8] Careggi Univ Hosp, Med Oncol Unit, Florence, Italy

[9] Grande Osped Metropolitano Niguarda, Niguarda Canc Ctr, Milan, Italy

[10] Ist Oncologico Veneto IRCCS, Med Oncol 2, Padua, Italy

[11] Regina Elena Natl Canc Inst IRCCS Rome, Oncol 1, Rome, Italy

[12] Ist Nazl Tumori IRCCS Fdn G Pascale, Thorac Med Oncol, Naples, Italy

[13] Univ Messina, AO Papardo & Dept Human Pathol, Med Oncol, Messina, Italy

[14] Campus Bio Medico Univ, Med Oncol, Rome, Italy

[15] IRCCS Humanitas Clin & Res Ctr, Humanitas Canc Ctr, Milan, Italy

[16] Sapienza Univ Rome, Policlinico Umberto, Med Oncol B, Rome, Italy

[17] Area Vasta 5 Asur Marche, Med Oncol, Ascoli Piceno, Italy

[18] Businco Oncol Hosp, Pathol & Oncol Unit, Cagliari, Italy

[19] St Marys Hosp, Dept Med Oncol, Terni, Italy

[20] Versilia Hosp, Dept Oncol, Lido Di Camaiore, Italy

[21] Univ Politecn Marche, Osped Riuniti Ancona, Oncol Clin, Ancona, Italy

[22] Univ Policlinico, Azienda Osped, Divis Med Oncol, Modena, Italy

来源：

JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 09期

关键词：

chemo-immunotherapy; lung adenocarcinoma; real-world;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EP08.01-00

引用

页码：S338 / S339

页数：2

共 50 条

[1] Final Analysis of First-Line Chemo-Immunotherapy in Patients with Advanced Lung Adenocarcinoma: An Italian Real-World Study
Leonetti, A.
Perrone, F.
Puntoni, M.
Bordi, P.
Maglietta, G.
Bria, E.
Gelsomino, F.
Gelibter, A.
Caliman, E.
Genova, C.
Guaitoli, G.
Passiglia, F.
Montrone, M.
Oresti, S.
Pasello, G.
Roca, E.
Pilotto, S.
Cecere, F. L.
Guida, A.
Manzo, A.
Russo, A.
Rastelli, F.
Bulotta, A.
Citarella, F.
Toschi, L.
Zoratto, F.
Cortinovis, D. L.
Paoloni, F.
Follador, A.
Carta, A.
Camerini, A.
Di Maio, M.
Tiseo, M.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S610 - S610
[2] Real-world analysis of outcomes of first-line chemo-immunotherapy in patients with extensive disease small cell lung cancer (ED-SCLC)
Zellweger, N. M.
Schmid, S.
Bertschinger, M.
Waibel, C.
Cerciello, F. W. F.
Froesch, P. R.
Mark, M. T.
Bettini, A.
Hauptle, P.
Blum, V.
Litke, T.
Helfenstein, F.
Frueh, M.
Mauti, L. A.
Rothschild, S. I.
[J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S1251 - S1251
[3] Combined chemo-immunotherapy as first-line treatment in patients with advanced/metastatic small cell lung cancer ("extensive disease") - a real-world, multicenter analysis
Zellweger, N.
Schmid, S.
Bertschinger, M.
Waibel, C.
Cerciello, F.
Froesch, P.
Mark, M.
Bettini, A.
Hauptle, P.
Blum, V
Litke, T.
Helfenstein, F.
Fruh, M.
Mauti, L.
Rothschild, S.
[J]. ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 207 - 207
[4] Real-world outcomes in advanced melanoma patients treated with first-line nivolumab plus ipilimumab
Kozak, Katarzyna
Teterycz, Pawel
Galus, Lukasz
Mackiewicz, Jacek
Galwas-Kliber, Katarzyna
Kaminska-Winciorek, Grazyna
Brandys, Piotr
Cybulska-Stopa, Bozena
Kempa-Kaminska, Natasza
Zietek, Marcin
Zubrowska, Justyna
Dziura, Robert
Dembinski, Mateusz
Bereza, Michal
Czarnecka, Anna Malgorzata
Rutkowski, Piotr
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[5] Real-world analysis of outcomes of first- line chemo-immunotherapy in patients with extensive disease small cell lung cancer (ED-SCLC)
Zellweger, N.
Schmid, S.
Bertschinger, M.
Waibel, C.
Cerciello, F.
Frosch, P.
Mark, M.
Bettini, A.
Hauptle, P.
Blum, V.
Litke, T.
Fruh, M.
Mauti, L.
Rothschild, S.
[J]. SWISS MEDICAL WEEKLY, 2022, 152 : 47S - 48S
[6] First-line Chemo-Immunotherapy in Advanced Non-Small Cell Lung Cancer with 0-49% PD-L1: A Real-world Experience
Benetti, B.
Ferro, A.
Girardi, F.
Calvetti, L.
Pavan, A.
Mulargiu, C.
Simionato, F.
Pretelli, G.
Lorenzi, M.
Resi, M. V.
Marinato, G.
Dal Maso, A.
Frega, S.
Pasello, G.
Aprile, G.
Morandi, P.
Guarneri, V.
Bonanno, L.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S341 - S341
[7] Real-World Data and Racial Outcomes for NSCLC in The Chemo-Immunotherapy Era
Markabawi, D.
Khan, M. A.
Alberti, M.
Tawagi, K.
Lopes, C.
Luk, E.
Satti, S.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1076 - S1077
[8] Real-world efficacy of docetaxel plus nintedanib after chemo-immunotherapy failure in advanced pulmonary adenocarcinoma
Metzenmacher, Martin
Rizzo, Filippo
Kambartel, Kato
Panse, Jens
Schaufler, Diana
Scheffler, Matthias
Azeh, Ivo
Hoiczyk, Mathias
Turki, Amin T.
Atz, Judith
Buchner, Hannes
Hoffmann, Christopher
Christoph, Daniel C.
[J]. FUTURE ONCOLOGY, 2021, 17 (30) : 3965 - 3976
[9] Clinical outcomes of first-line chemotherapy in locally advanced and metastatic pancreatic adenocarcinoma patients: Real-world experience
Umpawan, N.
Termsinsuk, P.
Kaosombatwattana, U.
Akewanlop, C.
Korphaisarn, K.
[J]. ANNALS OF ONCOLOGY, 2023, 34 : S919 - S920
[10] Real-World Efficacy and Safety of Thoracic Radiotherapy after First-Line Chemo-Immunotherapy in Extensive-Stage Small-Cell Lung Cancer
Xie, Zhaoliang
Liu, Jingru
Wu, Min
Wang, Xiaohan
Lu, Yuhan
Han, Chunyan
Cong, Lei
Li, Jisheng
Meng, Xue
[J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (11)

← 1 2 3 4 5 →